← Eichor
Study identifier: NCT06380686 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Head and Neck Carcinoma Clinical Research Platform for Molecular and Blood-based Biomarkers, Treatment and Outcome

Condition: Squamous Cell Carcinoma of the Oral Cavity · Squamous Cell Carcinoma of the Oropharynx · Squamous Cell Carcinoma of the Hypopharynx  ·  Sponsor: AIO-Studien-gGmbH

PhaseN/A
Planned participants120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Prospective, open, non-interventional, multi-center clinical registry study with the aim to establish a comprehensive research platform reflecting the real-world treatment landscape for recurrent/metastatic head and neck tumor patients.

This description comes directly from the study's public registry record.

Talk to the study team

Project Manager  ·  +49 (0)30 814534431  ·  kht-register@aio-studien-ggmbh.de

Always discuss trial participation with your own doctor first.

Locations (2)

Universitätsklinikum EssenEssen, GermanyNot Yet Recruiting
Onkologie/Studienzentrum am Raschplatz GbRHanover, GermanyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06380686